ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,265Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 1290

$1.46M Total Retail Price of All Prescriptions

Rank: 20 out of 1290

1,169 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 1,169 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 1,169 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 18,363 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,097 832 1 1
LEVOTHYROXINE SODIUM 726 578 2 4
WARFARIN SODIUM 708 626 3 22
FUROSEMIDE 658 552 4 9
LISINOPRIL 641 469 5 5
OMEPRAZOLE 615 460 6 2
METOPROLOL TARTRATE 597 482 7 7
AMLODIPINE BESYLATE 565 487 8 3
GABAPENTIN 447 274 9 8
DONEPEZIL HCL 418 367 10 13
CITALOPRAM HBR 400 347 11 29
METFORMIN HCL 323 235 12 10
HYDROCHLOROTHIAZIDE 319 258 13 20
NAMENDA 301 296 14 27
METOPROLOL SUCCINATE 293 261 15 14
POTASSIUM CHLORIDE 286 250 16 35
CLONIDINE HCL 276 146 17 66
LEVEMIR 263 189 18 256
NOVOLIN R 259 212 19 303
MIRTAZAPINE 255 222 20 93
LEVETIRACETAM 254 156 21 70
TRAMADOL HCL 245 169 22 25
RISPERIDONE 234 187 23 68
CARVEDILOL 231 184 24 12
EXELON 216 211 25 95
DIVALPROEX SODIUM 208 158 26 121
ISOSORBIDE MONONITRATE ER 195 187 27 58
LOSARTAN POTASSIUM 182 137 28 19
DIOVAN 178 146 29 53
CLOPIDOGREL 175 141 30 24
ALLOPURINOL 174 137 31 60
CIPROFLOXACIN HCL 172 136 32 46
ENALAPRIL MALEATE 166 119 33 62
SERTRALINE HCL 165 131 34 36
TAMSULOSIN HCL 165 145 34 11
ALBUTEROL SULFATE 163 99 36 319
MELOXICAM 161 91 37 31
PANTOPRAZOLE SODIUM 155 129 38 48
ATENOLOL 151 113 39 18
IPRATROPIUM BROMIDE 148 98 40 158
NITROGLYCERIN PATCH 147 100 41 212
ZOLPIDEM TARTRATE 147 98 41 15
OXYCODONE-ACETAMINOPHEN 143 109 S2 43 65
CARBIDOPA-LEVODOPA 131 114 44 43
LEVOFLOXACIN 131 109 44 150
FINASTERIDE 130 122 46 40
ATORVASTATIN CALCIUM 128 105 47 23
PLAVIX 127 112 48 32
PRAVASTATIN SODIUM 124 96 49 42
DIGOXIN 124 118 49 51
PREDNISONE 121 97 51 21
QUETIAPINE FUMARATE 120 96 52 80
OXYCODONE HCL 117 16 S2 53 33
AZITHROMYCIN 106 73 54 61
HYDROCODONE-ACETAMINOPHEN 105 87 S3 55 6
KLOR-CON M20 103 56 56 268
ADVAIR DISKUS 96 71 57 37
BACLOFEN 95 36 58 122
LAMOTRIGINE 93 73 59 100
NEXIUM 89 53 60 34
LANTUS 88 67 61 67
TRAZODONE HCL 88 35 61 44
GLYBURIDE 87 63 R 63 87
GLIPIZIDE 87 76 63 81
LABETALOL HCL 87 54 63 217
MEGESTROL ACETATE 86 79 R 66 198
PROAIR HFA 85 55 67 73
CYCLOBENZAPRINE HCL 84 55 R 68 105
FAMOTIDINE 84 59 68 128
CYMBALTA 84 30 68 59
FLUTICASONE PROPIONATE 83 57 71 26
NITROFURANTOIN MONO-MACRO 82 66 72 207
AGGRENOX 82 61 72 308
ADVAIR HFA 81 77 74 417
AMIODARONE HCL 80 77 75 300
FLUOXETINE HCL 80 57 75 79
TRIAMTERENE-HCTZ 79 68 77 130
CRESTOR 77 61 78 17
NIFEDIPINE ER 77 50 78 110
VENLAFAXINE HCL ER 77 51 78 154
CEPHALEXIN 71 56 81 139
TRILIPIX 70 25 82 313
NATEGLINIDE 70 63 82 280
IPRATROPIUM-ALBUTEROL 70 55 82 368
PHENYTOIN SODIUM EXTENDED 70 43 82 203
LATANOPROST 69 54 86 16
SPIRONOLACTONE 69 45 86 126
HYDROMORPHONE HCL 68 28 S2 88 145
TERAZOSIN HCL 66 57 89 157
TRANSDERM-SCOP 66 29 89 574
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 50 89 137
ENABLEX 65 63 92 229
GENERLAC 65 39 92 579
TOPIRAMATE 64 37 94 91
HYDRALAZINE HCL 63 43 95 133
AMOXICILLIN 63 40 95 227
BENZTROPINE MESYLATE 62 37 R 97 108
PAROXETINE HCL 62 53 97 84
KLOR-CON 10 61 36 99 291
SEROQUEL 60 48 100 186
LOVASTATIN 60 60 100 45
PREVACID 59 45 102 600
ESCITALOPRAM OXALATE 59 48 102 63
AMITRIPTYLINE HCL 58 23 R 104 97
GLIPIZIDE ER 58 30 104 206
INSULIN SYRINGE 58 42 104 76
AMOX TR-POTASSIUM CLAVULANATE 57 47 107 234
RANITIDINE HCL 57 53 107 49
PEN NEEDLE 55 40 109 72
LYRICA 55 34 109 94
ENULOSE 55 28 109 629
CLOTRIMAZOLE-BETAMETHASONE 54 44 112 153
BUSPIRONE HCL 54 46 112 178
MECLIZINE HCL 54 52 112 159
NOVOLOG FLEXPEN 53 39 115 129
NITROSTAT 53 43 115 160
DIOVAN HCT 53 50 115 112
PROPRANOLOL HCL 50 27 118 242
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.